Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) yield both the myeloid and lymphoid lineages of blood cells and can be reprogrammed into tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) to prevent tumor growth. However, the optimal approach for differentiating tumor Ag-specific CTLs from HSCs, such a...
Príomhchruthaitheoirí: | Xiaofang Xiong, Jugal Kishor Das, Jianyong Song, Bing Ni, Xingcong Ren, Jin-Ming Yang, Jianxun Song |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
MDPI AG
2018-07-01
|
Sraith: | Vaccines |
Ábhair: | |
Rochtain ar líne: | http://www.mdpi.com/2076-393X/6/3/40 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4
de réir: Lai Raymond, et al.
Foilsithe / Cruthaithe: (2011-09-01) -
The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo
de réir: Melissa A. Edwards, et al.
Foilsithe / Cruthaithe: (2020-07-01) -
Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation
de réir: Yan Man, et al.
Foilsithe / Cruthaithe: (2021-01-01) -
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
de réir: Jing Ma, et al.
Foilsithe / Cruthaithe: (2025-03-01) -
An Overview of Autophagy in Hematopoietic Stem Cell Transplantation
de réir: Soheila Montazersaheb, et al.
Foilsithe / Cruthaithe: (2022-05-01)